The BioTech and pharmaceutical industries are under increasing pressure to safeguard highly sensitive data and clinical information. However, despite email remaining critical to sharing this information, many organisations still fail to have proper email management in place.
Ineffective email and document management can be hugely damaging for pharma firms. Failing to safeguard sensitive data can result in financial and legal damage and disrupt clinical research and drug development pipelines. However, many organisations still aren’t adequately protecting themselves against accidental data loss, which becomes more critical as the risks they face continue to grow.
Fill out the form to get the rest of the guide...
